Skip to Main Content

Paper Details

Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Oncol
208
2018
Anastrozole, BCI, Breast Cancer, EPclin, ER, ER-positive breast cancer, ERBB2, Estrogen, Estrogen Receptor, Estrogen Receptor-Positive Breast Cancer, HER2, Participants, ROR, Tamoxifen, anastrozole, estrogen, estrogen receptor, estrogen receptor (ER)-positive breast cancer, multigene signatures, patient, patients, tamoxifen, women
Author NameAffiliation
Dennis C SgroiCancer Center, Massachusetts General Hospital
Elizabeth MallonUniversity of Glasgow
  • 1 - 2

Datasets

Release 1.2